Kangstem Biotech Co., Ltd. products

FURESTEM-OA Kit Inj., a therapeutic biological product, is composed of allogeneic umbilical cord blood-derived mesenchymal stem cells (FURESTEM-OA Inj.), as a major active component for repairing tissue damage, and cartilage acellular matrix (CAM Inj.), a medical device, as a supportive material. This convergence medical product is under development for the treatment of osteoarthritis patients with knee cartilage damage.

FURESTEM-AD Inj. is the world’s first stem cell therapeutic product for atopic dermatitis that targets moderate to severe atopic dermatitis patients.

FURESTEM-RA Inj. targets moderate to severe rheumatoid arthritis patients.